The spin labeled nitrosoureas 7 a-e and 12 were synthesized and evaluated in vivo for their anticancer activities against the murine lymphocytic leukem ia P388. C om pounds 7 a -c, 7 e and 12 possessed activities ranging from 31 to 542 percent increase in life span (% IL S ), w hereas com pound 7 d was marginal (% IL S = 21). All CD2Fj male mice treated with the most active com pounds (7a and 12) at 35 mg/kg for 9 days were alive after 30 days, w hereas all mice treated with the clinical drug CCNU (lc ) succumbed. Compounds 7 a -e and 12 were further evalu ated for their antineoplastic activity against lymphoid leukem ia L1210. C om pounds 7a and 12 exhibited, on day 60, a % ILS of 713 and 620, respectively. The lipophilicities of com pounds 7 a -e and 12 were determ ined using the E PR and UV methods. Compounds 7a and 12 which differ from CCNU and M eCCNU by the replacement of the cyclohexyl and methylcyclohexyl groups with six and five m em bered nitroxyl radical moieties were more hydrophilic than the clinical drugs.
Introduction
A lk y lnitrosoureas o f the general form ula la have b een know n for som etim e [1-4] to be highly car cinogenic and m utagenic. A lthough these properties have b een thoroughly studied over the past tw o de cades [ 1 -8 ], none of the com pounds found a practi cal ap plication in th e m edicine. In contrast, the rela ted 2 -ch lo roethylnitrosoureas (C E N U s), such as, N ,N '-b is(2 -ch lo ro eth y l)-N -n itro so u rea (B C N U , lb), N '-cyclohexyl-N -(2-chloroethyl)-N -nitrosourea (C C N U , lc) and N '-(trans-4-m ethylcyclohexyI)-N -(2 -ch lo ro eth y l)-N -n itro so u rea (M eC C N U , Id) have b een extensively used clinically for the trea tm e n t of a w ide v ariety of hum an and anim al neoplasm s [3] [4] [5] [6] [7] [8] [9] [10] [11] . T h eir structure-activity relationship has been investi gated [6 , 9 -11] . R eprint requests to Prof. G. Sosnovsky.
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It ap p ears, th a t in co n trast to o th e r antican cer agents, such as, anthracyclines, bleom ycin, m itom y cin C and strep to n ig rin w hich req u ire activation p rio r to th eir in teractio n s w ith th e cell targ ets, th e C E N U s react in the cell w ithout activation [12] [13] [14] [15] [16] [17] , although th ey are subject to oxidative m etabolism at th e alkyl group [18, 19] . T h u s, they d ecom pose spontaneously u n d er physiological conditions to give electrophiles, such as 2 -chloroethyldiazohydroxide or 2 -chloroethyl cation [20] [21] [22] [23] [24] w hich und erg o alkylation an d /o r in te rstra n d cross-linking of the D N A and biological pro tein s. T he o th e r decom position p ro d u cts, the al kyl isocyanates [25, 26] lead to th e carbam oylation of am ino groups in th e biological m acrom olecules. E x tensive studies on th e m echanism o f action of these agents, including the use of 15N and l3C labeled C E N U s, led to a p ro p o sal involving th ree different pathw ays [27]: 1. fo rm atio n of alkyl isocyanates and chloroethyl d iazohydroxide, 2 . fo rm atio n of 2 (alkylim ino)-3-nitrosooxazolidine, and 3. fo rm atio n of N -acyloxadiazolium species. B ecause of th eir n o n specificity, like o th e r alkylating an tineoplastic agents, such as, T E P A (2a) and T h io -T E P A (2b), th e C E N U s exhibit a w ide range of cytotoxic effects In th e search for m ore active an d /o r less toxic d e rivatives o f 2a and 2b, th e rep lacem en t of one of the aziridine groups w ith th e nitroxyl radical and its re d uced form s, led to th e discovery of a T E P A deriv a tive 3 a [28] w hich has a higher th e ra p eu tic index (26.5) th an th a t (2.75) of the clinically used drug 2b. It was show n th a t w hile the nitroxyl m oiety im p arts a benefical influence on the antineoplastic p ro p erties of a drug [28], the nitroxyl radical by itself has no anticancer activity [29] , is relatively non-toxic [29] , is not carcinogenic or m utagenic [30] , exhibits no synergistic effect [31] , and has little effect on the cell grow th and on the cell cycle kinetics [32] , This phen o m en o n can be explained by o u r hypothesis th at th e nitroxyl radical is a carrier m oiety w hich facili tates the tran sp o rt of the drug through the biological m em branes on its way to the cellular D N A .
In support of this hypothesis, it was foun d th at neutral or w eakly acidic o r basic nitroxyls are [3 3 ] rapidly perm eatin g through cell m em branes, and th a t a plausible correlatio n of the antineoplastic activity of com pounds 2, 3 and analogs w ith th eir lipophilic p ro p ertie s can be established [34, 35] , It is know n th a t B C N U (lb), C C N U (lc) and M eC C N U (ld) rapidly e n te r the cerebrospinal fluid and thus can be used to control the m eningeal tum ors [36, 37] , F u rth e r, the nitroxyl radicals are know n to cross the blood brain b arrier [38] at the site o f the diseased tissue. H en ce, we assum ed th a t a com b in a tion of the ch lo ro eth y ln itro so u rea and the nitroxyl m oiety could lead to a m ore viable drug w hich could be follow ed pharm acokinetically by E S R in anim al m odels, and diagnostically during th erap y by N M R im aging [39] . T hus, a replacem ent of th e cyclohexyl m oiety in C C N U with nitroxyl radical m oieties co n taining the five and six m em b ered rings led to the d evelopm ent of nitroxyl labeled drugs 7a and 12.
In o rd er to establish th at the ta u to m eric p ro to n on the N ' position in 7a and 12 is essential for the level of antineoplastic activities of these drugs, several ni tro so u reas (7b-d) w ere p rep ared by replacing the tau to m eric p ro to n w ith m ethyl, cyclohexyl, and nitroxyl m oieties. In ad d itio n , the bifunctional " nonta u to m e ric" chloronitroso derivative 7 e was also synthesized, since it was rep o rted [8 ] th a t som e of this type o f bifunctional chloroethyl n itro so u reas ex hibit significant activity against W alk er carcinom a 256 in rats. In 1985 we rep o rted som e prelim in ary results [40, 41] concerning th e an tican cer activity o f these com pounds. A t th a t stage no co rrelatio n of th e an ticancer activity w ith lipophilicity an d no ex p eri m ental details w ere described. A fte r co m pletion of o u r w ork several studies cam e [42] [43] [44] to o u r a tte n tion. O ne of these studies [42] was essentially in agreem en t w ith o u r results concerning th e high levels of activity of com pounds 7a and 12, w hereas th e o th e r study [44] could not confirm th e activity o f 7a.
In addition, these studies [4 2 -4 4 ] are substantially different in rationale of design, in te rp re ta tio n an d in detail of approach. C om pounds 7 a and 12 w ere also synthesized by a different approach using 2 -chloroethylnitrosocarbam oyl azide [43] .
Results and Discussion

Chem istry
Biological
C om pounds lc , 7a-e and 12 w ere tested in vivo against the m urine lym phocytic leukem ia P388 in C D 2Fj m ale mice according to the N ational C ancer
In stitu te protocol [46] . C om pounds 7 a and 12 at a dose of 35 mg/kg/day possessed ou tstan d in g activity w ith a % IL S values of 542 and 514, respectively. In T he L D 5o fo r co m p o u n d 7 a (123 mg/kg) was about twice as high as th a t (56 mg/kg) for the clinically used drug C C N U . T he L D 50 for com pounds 7 b and 7c was 353 and 337 m g/kg, respectively. C om pounds 7b-e which are d evoid of a tau to m eric p ro to n on the N ' position ex h ib ited a substantial low ering of activities as co m p ared to th e ta u to m e ric spin labeled nitroso u reas. O n th e basis of this result, it seem s th at a tau to m eric p ro to n decisively co n trib u tes to the activ ity of the spin labeled n itro so u reas. T he com pounds l c , 7 a -e and 12 w ere th en tested against the lym phoid leu k em ia L1210. T h e com pounds 7a and 12 elicited at th e optim um dose of 60 m g/kg/day a % ILS of 713 and 612, respectively. T he clinical drug CC N U at a dose of 25 m g/kg/day has a % IL S of 646. The m edian survival tim es fo r 7a and 12 w ere 61/7.5 and 54/7.5, respectively, w h ereas for C C N U it was 56/7.5.
T he th e ra p eu tic index fo r com pound 7a was about eight tim es an d th a t for com pound 12 was about five tim es higher th an th a t fo r the clinical drug CC N U (T able II). [47, 48] . Ref. [55] . In ref. [56] , the ILS (% ) for CCNU is 172 (NCI protocol followed). In ref. [57] , 2.83. Ref. [56] (NCI protocol followed). In ref. [57] , 3.30.
In o rd e r to establish a m easurable and p redictable p ara m ete r for the correlatio n of activities of drugs l c , Id , 7 a -e and 12 w ith the presum ed p erm eation th ro u g h cell m em branes, an attem p t was m ade to relate the lipophilicities of drugs lc . Id , 7 a -e and 12 to th eir structural featu res and to the levels of their an tican cer activities. F or this purp o se, the partition coefficients for these drugs w ere d eterm in ed in the n -o ctan ol/w ater solvent system by using E S R and/or U V m ethodologies [47, 48] . T he results are sum m arized in T able I. T he low er the p (o r log p ) values, th e higher is the hydrophilicity of a com pound.
A lth o u g h all com pounds ( lc , Id , 7 a -e, 12) w ere w ater soluble th eir p artitio n coefficients varied over a w ide range.
A s ex pected, th e re was a good correlatio n o f activity-lipophilicity relationship am ong com pounds lc , Id , 7a, and 12 containing a ta u to m e ric p ro to n , w hereas no plausible correlatio n could be established in th e case of com pounds 7 b-e containing no tau to m eric p ro to n . H ow ever, all com pounds ( l c . I d .
7 a , and 12) w ith a ta u to m eric p ro to n w ere substan tial ly m ore active, than all com pounds (7b-e) devoid of a tau to m eric p ro to n . In the series l c , Id , 7a, and 12, the clinical drug M eC C N U (Id ) was the m ost hydrophobic and possessed concom itantly the low est activi ty. C C N U was less hydrophobic than Id and exhi bited a higher activity than Id. B oth com pounds 7a and 12 w ere substantially m ore hydrophilic than l c and Id , and at the sam e tim e m ore active, w hereby co m pound 7 a was the m ost hydrophilic and also the m ost active drug in this series (T able I). T his result is essentially in agreem ent w ith a prediction based on a d ifferent series of "ta u to m e ric " n itro so u reas [6 , 1 1 ] th a t the m ost hydrophilic n eutral cong en er should exhibit the highest activity.
Experimental Section
M aterials
A ll reagents w ere of th e finest quality com m ercial ly available. Solvents w ere dried by sta n d ard p ro ce dures [49] . C om pounds 4 and 8 [50] and com pounds 5a, 5b, and 5d [51, 52] [47, 48] using U V spec tro p h o to m e try and E P R spectroscopy. F o r m e asu r ing the p artitio n coefficients, 1 -octanol and w ater layers w ere p resa tu rate d w ith each o th e r p rio r to use. T hus, th e areas o f th e d o uble integrals of the first derivative curves of th e E P R spectra o f th e co r responding spin labeled nitro so u reas (3 m l, 5 mM solutions) w ere co m puted. T he areas of the initial octanol solutions and th e se p arate d w ater solutions w ere used to com pute th e co n cen tratio n s of th e spin labeled com pounds in o ctanol and in th e w ater layer. T he p artitio n coefficients [com pound in 1 -octanol] . .
A nalytical procedures
A ll m elting points w ere o b tain ed w ith a T hom as-H o o v er capillary m elting p o in t ap p a ratu s, M odel 6406-K, using a calibrated th e rm o m ete r. M ass spec tra w ere reco rd ed on a H ew lett P ackard M ass Spec tro m e ter, M odel 5985 G S, using a direct insertion p ro b e, a source pressu re o f 2 x l 0 -7 to rr, and m eth an e as a reactan t gas for chem ical ionization. IR spectra w ere reco rd ed on a P erk in -E lm er spec tro p h o to m e te r, M odel 735 B. M icroanalyses w ere p erfo rm ed eith er on a F & M Scientific C o rp o ratio n carb o n , hydrogen, n itrogen analyzer. M odel 185 or on a P erk in -E lm er 240 C E lem en tal A nalyzer. The E
P = ------------------------------------and th e ir logarithm ic
[com pound in w ater] values so o b tain ed w ere co m p ared w ith th e ir co rre sponding values o b tain ed by using U V m ethodology [48] . A ll these values are show n in T able I. (Tables I and II) .
Biological evaluations
C om pounds l c , 7 a -e and 12 w ere evaluated in vivo against th e lym phocytic leukem ia P388 and lym phoid leukem ia L 1 2 1 0 in mice follow ing the protocol o f th e N atio n al C ancer In stitu te [46] . (R f = 0.6) and one m inor im purity. T he red oily m aterial was purified by colum n chrom atography on basic alum ina using first f-butylm ethyl e th e r to afford 1.74 g (58% ) of 5 d and then r-butylm ethyl e th e r and m eth an o l (90:10, v/v) to afford 1.14 g (38% ) of 5a. F u rth e r purification of 5 a by K ugelrohr distillation 
Preparation o f 4-am ino-2,2,6,6-tetram ethylpiperid in e -l-o x y l (5 a ) and bis(2,2,6,6-tetram ethylpiperid in e-l-o xyl-4 -yl)-am ine (5d)
To
Preparation o f 4-alkyl substituted am ino-2,2,6,6-tetram ethylpiperidine-l-oxyls (5 b and 5 c)
T o a solution of 4 (2.50 g, 14.0 m m ol) in m ethanol (25 ml) was added the corresponding alkylam ine (16.0 m m ol and sodium cyanoborohydride (0.62 g, 9.8 m m ol) at 24 °C. T he reaction m ixture was stirred for 24 h at 24 °C and then h ea te d u n d er reflux for 4 h. T he solvent was rem oved on a rotating ev a p o rato r at 40 °C/20 to rr. T he resulting oily re sidue was dissolved in w ater ( 2 0 m l) and sa tu ra te d w ith sodium chloride and th en ex tracted w ith chlo ro fo rm ( 4 x 2 0 m l). T he com bined organic ex tracts w ere w ashed w ith a 5% aqueous citric acid solution (2 x 10 m l). T he sep arated organic layer was dried o v er anhydrous m agnesium sulfate and fil te re d . T h e filtrate was co n cen trated on a ro tatin g e v a p o ra to r at 25 °C/20 to rr. T he crude oily residue thus o b ta in ed was purified by flash colum n ch ro m ato g rap h y on silica gel using chloroform and m eth an o l (90:10, v/v) as eluant. T he co n cen tratio n of th e co m b in ed fractions containing the p ro d u ct on a ro tatin g e v a p o rato r at 25 °C/20 to rr, gave eith er p ure 5b (lit. [51] , liquid) or p u re 5c. T he yield and an aly ti cal d ata for 5 c are p resen ted in T able III.
Preparation o f N ,N '-b is (2,2,6,6-tetramethylpiperidine-1 -oxyl-4-yl)-ethylenediam ine (5e)
U sing th e preceeding pro ced u re sim ilar to th a t d escrib ed for 5b and 5c, th e reaction m ixture was stirred fo r 54 h at 24 °C. T he crude p ro d u ct was p u ri fied by ch ro m ato g rap h y on basic alum ina using ch lo ro fo rm an d m eth an o l (9:1, v/v) as eluant. R e m oval of th e solvent on a rotating ev a p o rato r at 24 °C/20 to rr gave p ure p ro d u ct 5 e . T he yield and analytical d ata are p resen ted in T able III. chloride (20 ml) at -10 °C. T he reaction m ixture was stirred for 4 h at -10 °C and for 16 h at 24 °C. T h e reaction m ixture was w ashed w ith w ater ( 2 x 5 ml) and then dried over anhydrous m agnesium sulfate and filtered. T he filtrate was co n cen trated on a ro tatin g ev a p o rato r at 24 °C/20 to rr. T he resulting residue was purified by flash chrom atography on sili ca gel using m ethylene chloride and m ethano l (9:1, v/v) as eluant. T he corresponding ureas w ere o b tain ed in pure form . T he yields and analytical d ata are p rese n ted in T able IV. Table V . Physical properties of l-(2-chloroethyl)-3-substituted-l-nitrosoureas. -(2-chloroethyl)-3-(2,2 ,6 ,6 ,- 
Preparation o f N -(2-chloroethyl)-N '-substituted ureas ( 6 a -e a n d 11). A general procedure
Preparation o f N -(2-chloroethyl)-N '-substituted-Nnitrosoureas (7a-e and 12). A general procedure
Preparation o f l
Preparation o f N ' -hydroxysuccinim ide-N -(2-chloroethyI)-carbam ate (14)
T he literatu re p rocedure was m odified as follows. 
